STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2019

The following is a summary of transactions pertaining to restricted stock:

	Shares			Weighted Average Grant Date Fair Value Per Share
Nonvested restricted stock outstanding at December 31, 2017		607,994		$	1.90
Granted		135,568			1.60
Cancelled		-			-
Vested		(707,654	)		1.82
Nonvested restricted stock outstanding at December 31, 2018		35,908			2.23
Granted		598,982			3.15
Cancelled		(3,546	)		3.17
Vested		(35,908	)		2.23
Nonvested restricted stock outstanding at December 31, 2019		595,436			3.15

During 2019, 2018 and 2017 there were no new stock option grants. The following is a summary of transactions pertaining to the option plans:

	Shares			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding January 1, 2017		218,167		$	12.11	3.33 years	$	-
Cancelled		(50,500	)		12.09			-

Outstanding December 31, 2017		167,667			12.11	2.97 years		-
Cancelled		(28,667	)		11.98			-

Outstanding December 31, 2018		139,000			12.14	2.53 years		-
Cancelled		(23,000	)		20.15

Outstanding December 31, 2019		116,000			10.56	1.83 years		-

Vested as of December 31, 2019		116,000			10.56	1.83 years		-

Exercisable as of December 31, 2019		116,000			10.56	1.83 years		-

The following table presents a summary of options outstanding at December 31, 2019:

		At December 31, 2019
		Stock Options Outstanding						Stock Options Exercisable
Range of Exercise Prices		Shares		Contractual Weighted Average life (years)		Weighted Average Exercise Price		Shares		Weighted Average Exercise Price
$	7.79		91,000		2.17	$	7.79		91,000	$	7.79
$	20.62		25,000		0.59		20.62		25,000		20.62

			116,000		1.83		10.56		116,000		10.56